'Are people to be left to die?' Vaccine pleas fill UN summit

JOHANNESBURG (AP) — If the United Nations was created from the ashes of World War II, what will be born from the global crisis of COVID-19? Many world leaders at this week’s virtual...

Telling COVID's story: At UN, leaders spin virus storylines

The subject: coronavirus. The status: urgent. The solutions: as diverse as the nations they lead. With the 75th annual U.N. General Assembly reduced to recorded speeches because of t...

As Europe faces 2nd wave of virus, tracing apps lack impact

LONDON (AP) — Mobile apps tracing new COVID-19 cases were touted as a key part of Europe’s plan to beat the coronavirus outbreak. Seven months into the pandemic, virus cases are surging again and the ...

Former Canadian Prime Minister John Turner has died at 91

TORONTO (AP) — John Turner, a Liberal party politician who served stints as Canada's justice and finance ministers before a very brief turn as the country's 17th prime minister, has died at age 91, hi...

South Africa says 12 million 'probably' had coronavirus

CAPE TOWN, South Africa (AP) — About 12 million people in South Africa have “probably” been infected with the coronavirus, but that startlingly high number has not caused a similarly high death rate a...

UK tests if COVID-19 vaccines might work better inhaled

LONDON (AP) — British scientists are beginning a small study comparing how two experimental coronavirus vaccines might work when they are inhaled by people instead of being injected. ...

The Latest: India's cases rise to 4.75M with another spike

NEW DELHI — India has registered a single-day spike of 94,372 new confirmed coronavirus cases, driving the country’s overall tally to 4.75 million. The Health Ministry on Sunday also...

Oxford, AstraZeneca to resume coronavirus vaccine trial

LONDON (AP) — Oxford University says trials of a coronavirus vaccine that it is developing with pharmaceutical company AstraZeneca will resume, days after being paused due to a reported side-effect in...

Vaccine trial stopped after neurological symptoms detected

LONDON (AP) — A woman who received an experimental coronavirus vaccine developed severe neurological symptoms that prompted a pause in testing, a spokesman for drugmaker AstraZeneca said Thursday. ...

Halt of coronavirus trial is "safety valve" at work: Fauci

The top U.S. infectious disease expert said AstraZeneca’s suspension of final testing of its COVID-19 vaccine candidate shows “one of the safety valves” built into the studies to spot any potential pr...

AstraZeneca COVID-19 vaccine study paused after one illness

Late-stage studies of AstraZeneca's COVID-19 vaccine candidate are on temporary hold while the company investigates if a report of a patient with a serious side effect is linked to the shot. ...

Russia publishes virus vaccine results, weeks after approval

MOSCOW (AP) — Russian scientists have belatedly published first results from early trials into the experimental Sputnik V vaccine, which received government approval last month but drew considerable c...

Analysis: China's rise takes the world into uncharted waters

BEIJING (AP) — Twice in the 20th century, Japan challenged the West, first in a military-led attempt to become an imperial power and then as an industrial powerhouse. Now it is China’s turn to take th...

Third virus vaccine reaches major hurdle: final US testing

A handful of the dozens of experimental COVID-19 vaccines in human testing have reached the last and biggest hurdle — looking for the needed proof that they really work. AstraZeneca...

UK to allow emergency use of any effective COVID-19 vaccine

LONDON (AP) — Britain is preparing to revise its laws to allow the emergency use of any effective coronavirus vaccine before it is fully licensed — but only if the shots meet required safety and quali...